10 Stocks Jim Cramer Mentioned As He Talked About “Love Lost” Between Microsoft & OpenAI

5. Moderna, Inc. (NASDAQ:MRNA)

Number of Hedge Fund Holders In Q1 2025: 44

Moderna, Inc. (NASDAQ:MRNA) has been one of the most ill-fated stocks in 2025. The shares have lost 38% year-to-date as the firm has struggled to diversify away from its mRNA vaccines amidst slipping demand for the products. For instance, Moderna, Inc. (NASDAQ:MRNA)’s full-year revenue guidance of $1.5 billion to $2.2 billion given during its second quarter earnings was lower than the earlier guidance of $1.5 billion to $2.2.5 billion. The reason behind the trimmed guidance was deferred revenue from its COVID vaccines. Cramer discussed Moderna, Inc. (NASDAQ:MRNA) in the context of RFK Jr:

“Hey that’s got the double whammy. It’s vaccine, got a guy at HHS doesn’t like it, they never did anything with the other one.”

The CNBC TV host discussed Moderna, Inc. (NASDAQ:MRNA) in May. Here is what he said:

“There’s gotta be some value in Moderna. There just has to be, but I’ve been against this stock for so long. I first discovered it at 18. Maybe that should be the price target.”